Text Size

Non Invasive Diagnostic of Endometrial Receptivity

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Carlos Simon, Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:
NCT01588223
First received: April 26, 2012
Last updated: April 3, 2013
Last verified: April 2013
History of Changes
  Purpose

The purpose of this study is to determine a lipidomic profile on the endometrial fluid, that can predict endometrial receptivity.


Condition Intervention
Endometrial Receptivity Failure
 Other: Lipid identification

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: A Non Invasive Diagnostic of Endometrial Receptivity Based on Lipidomic Profile on Endometrial Fluid.

Further study details as provided by Instituto Valenciano de Infertilidad, Spain:

Primary Outcome Measures:
  • Levels of lipids in the endometrial fluid as a diagnostic factor. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 40
Study Start Date: January 2011
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lipids Other: Lipid identification
The lipids are identified using Mass Spectrometry

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Oocyte donors undergoing controlled ovarian stimulation
  • Regular menstrual cycles
  • no abnormal karyotype
  • generally healthy
  • BMI 19-29 Kg/m2 (both inclusive)
  • 18 to 35 years old.

Exclusion criteria:

-patients diagnosed with endometriosis and/or endometritis.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01588223

Locations
Spain
IVI Valencia
Valencia, Spain, 46015
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, Spain
  More Information

No publications provided

Responsible Party: Carlos Simon, Prof. Carlos Simon, MD PhD, Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier: NCT01588223     History of Changes
Other Study ID Numbers: 1002-C-069-OB
Study First Received: April 26, 2012
Last Updated: April 3, 2013
Health Authority: Spain: Ministry of Health

Additional relevant MeSH terms:
Adenoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on May 22, 2013